A Neuropharmacokinetic Assessment of Bafetinib, a Second Generation Dual BCR-Abl/Lyn Tyrosine Kinase Inhibitor, in Patients with Recurrent High-Grade Gliomas

PURPOSE: The primary objective of this study was to use intracerebral microdialysis (ICMD) to determine the neuropharmacokinetics of bafetinib, a dual BCR-Abl/Lyn tyrosine kinase inhibitor that may have activity against gliomas. METHODS: A microdialysis catheter was placed into either peritumoral or...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Portnow, Jana, Badie, Behnam, Markel, Susan, Liu, An, D'Apuzzo, Massimo, Frankel, Paul, Jandial, Rahul, Synold, Timothy W.
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4172445/
https://ncbi.nlm.nih.gov/pubmed/23380277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2013.01.001
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items